← Back to Clinical Trials
Recruiting NCT07792837

NCT07792837 An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07792837
Status Recruiting
Phase —
Sponsor San Diego State University
Condition Excessive Gestational Weight Gain
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-11
Primary Completion 2027-08

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Intuitive Eating Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-11 with a primary completion date of 2027-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this feasibility randomized controlled trial is to assess the feasibility, acceptability, and demand, as well as preliminary effects of an evidence-based Intuitive Eating (IE) intervention among pregnant women who have obesity. The main research questions are: RQ1: What is the feasibility (acceptability and demand) of implementing an Intuitive Eating Intervention among pregnant and postpartum women? RQ2: How does participation in the Pregnancy Intuitive Eating Intervention (PIE-I) impact key maternal health outcomes (i.e., gestational weight gain, intuitive eating behaviors, dietary quality, body image, and mental health) compared to a wait-list control? Researchers will compare the Pregnancy Intuitive Eating Intervention (PIE-I) intervention group with the wait-list control to see what impact the PIE-I has on maternal well-being. Participants randomized to the intervention group will complete the 8 week asynchronous IE intervention and have an opportunity to interview at the end of the study.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Pregnant women between 12 weeks and \<22 weeks gestation * Pre-pregnancy BMI 30.0 kg/m² or greater * Able to read and understand English (for intervention materials and questionnaires) * Receiving prenatal care at UC San Diego Health (UCSD) * Reliable access to a device (e.g., smartphone, tablet, or computer) with internet connection Exclusion Criteria: * Current or past diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID) * High-risk pregnancy or medical complications that may significantly affect diet, physical activity, or weight gain (e.g., gestational diabetes requiring insulin, preeclampsia, hyperemesis gravidarum) * Multiple gestation pregnancy (e.g., twins or higher-order multiples) * Current participation in another nutrition, weight management, or behavioral intervention study * Severe psychiatric illness (e.g., schizophrenia, bipolar disorder) or current substance use disorder that would interfere with participation * Inability to provide informed consent or comply with study procedures

Contact & Investigator

Central Contact

Jeni Green, PhD

✉ jgreen5@sdsu.edu

📞 619-594-6489

Frequently Asked Questions

Who can join the NCT07792837 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Excessive Gestational Weight Gain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07792837 currently recruiting?

Yes, NCT07792837 is actively recruiting participants. Contact the research team at jgreen5@sdsu.edu for enrollment information.

Where is the NCT07792837 trial being conducted?

This trial is being conducted at San Diego, United States, San Diego, United States.

Who is sponsoring the NCT07792837 clinical trial?

NCT07792837 is sponsored by San Diego State University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology